Materialise N.V.

MTLS • Software - Application

$7.46

▲ +0.43 (+6.12%)

Precio actual

ResultadosÚltimo reporte: 31 mar 2026

PERFIL DE MAYOR RIESGOPrecauciónConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Conviene actuar con cautela. Los ratios recientes muestran debilidades que pueden limitar el retorno si los fundamentales no mejoran.

Capitalización

$439.13M

Crecimiento

—

Flujo de caja

4/5

Tendencia

Mostly stable

Evidencia

Flujo de caja libre positivo · 0.15Flujo de caja libre consistente · 4/5Nivel de deuda manejable · 0.26Liquidez saludable · 2.43Múltiplo de ganancias caro · 37.64

Datos financieros hasta: 31 mar 2026, 12:00 a.m. UTCÚltima actualización de earnings: 7 may 2026, 12:00 a.m. UTCÚltima actualización del perfil: 28 ago 2026, 12:14 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$7.46

Change6.12%

Shares Out58.87M

Market Cap$439.13M

52W Range4.78 - 7.50

Beta1.35

P/E34.74

P/S3.82

P/B0.99

P/FCF46.46

EV/Sales2.70

EV/EBITDA20.24

Price$7.46

Change6.12%

Shares Out58.87M

Market Cap$439.13M

52W Range4.78 - 7.50

Beta1.35

P/E34.74

P/S3.82

P/B0.99

P/FCF46.46

EV/Sales2.70

EV/EBITDA20.24

EV/FCF32.83

Earnings Yield2.88%

FCF Yield2.15%

Dividend Yield0.00%

Gross Margin57.15%

Oper. Margin1.92%

Profit Margin2.88%

Debt/Eq0.26

Current Ratio2.43

Quick Ratio2.27

Target$10.00

Target Upside34.05%

Target Median$10.00

Target Range10.00 - 10.00

Volume498.97K

Avg Volume114.92K

EPS Surprise0.03

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

35/100

Fortaleza financiera

Deuda, caja, estabilidad

76/100

Potencial de crecimiento

Ingresos y expansión

43/100

Atractivo del precio

Barata o cara hoy

70/100

Por qué este puntaje▼

Flujo de caja libre positivo · 0.15Flujo de caja libre consistente · 4/5Nivel de deuda manejable · 0.26Liquidez saludable · 2.43Múltiplo de ganancias caro · 37.64Rentabilidad débil

Analyst view

Analyst sentiment and price target

MTLS

Analyst sentiment

Based on 12 analyst votes · 2026-09-05

83/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-28

Bajo

$10.00

Promedio

$10.00

Mediana

$10.00

Alto

$10.00

Resumen de la compañía

IPO: 6/25/2014

Industria: Software - Application

P/B i: 0.99

Deuda / Patrimonio i: 0.26

Margen operativo: 1.92%

Margen neto: 2.88%

ROE i: -

ROIC: -

Salud financiera

Puntaje15 / 20

Deuda / Patrimonio: 0.26

Ratio corriente: 2.43

Ratio rápido: 2.27

Estado: Good

🧾

No hay actividad interna

No hay transacciones internas recientes disponibles.

Sobre la compañía

Materialise N.V.

Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.

Fuente - Link

Competidores

BKKT CMRC EGAN GRRR LAW MITK PUBM RMNI RPAY RXT

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Materialise Q2 Earnings Call Highlights

Materialise (NASDAQ: MTLS) reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses. Chief

Defense World

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Seeking Alpha

Materialise Q2 Earnings Call Highlights

Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.

MarketBeat

Materialise Reports Second Quarter and Half-Year 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026. Highlights – Second Quarter 2026 Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period. Adjusted EBITDA increased.

Business Wire

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the second quarter and the six months ended June 30, 2026 on Thursday, August 27, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the second quarter and the six months ended June 30, 2026 fina.

Business Wire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-07	0.01155	0.04	0.02845
2026-02-19	0.07047	0.12	0.04953
2025-10-28	0.01	0.04	0.03
2025-07-24	0.01	0.00397	-0.00603
2025-04-24	0.02	-0.01	-0.03
2025-02-20	0.05	0.05	0
2024-10-24	0.025	0.05	0.025
2024-07-31	0.05	0.07	0.02
2024-04-25	-0.00539	0.06	0.06539
2024-02-21	0.06	0.07	0.01
2023-10-26	0.01	0.07	0.06
2023-07-26	0.05	-0.01	-0.06